MaxCyte Licenses Flow Electroporation Tech to Pharma Giant
Ticker: MXCT · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1287098
Sentiment: neutral
Topics: collaboration, licensing, technology
Related Tickers: MXCT
TL;DR
MaxCyte just inked a big tech license deal with a major pharma player – potential for huge future payouts!
AI Summary
MaxCyte, Inc. announced on June 18, 2025, that it has entered into a collaboration and license agreement with a leading global pharmaceutical company. This agreement grants the partner rights to use MaxCyte's Flow Electroporation Technology for the development of novel cell therapies. The financial terms include an upfront payment and potential milestone payments, though specific dollar amounts were not disclosed in this filing.
Why It Matters
This licensing deal signifies external validation of MaxCyte's core technology and opens up new avenues for its application in the lucrative cell therapy market.
Risk Assessment
Risk Level: medium — While the deal is positive, the actual financial impact depends on the partner's success in developing cell therapies using MaxCyte's technology, which carries inherent development risks.
Key Players & Entities
- MaxCyte, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40674 (identifier) — Commission File Number
- 52-2210438 (identifier) — IRS Employer Identification No.
- 9713 Key West Avenue, Suite 400 (address) — Business and Mail Address
- Rockville, MD 20850 (address) — Business and Mail City, State, Zip
FAQ
What is the primary purpose of this Form 8-K filing?
This Form 8-K is a current report filed by MaxCyte, Inc. to announce significant corporate events, including potential changes in directors or officers, matters submitted to security holders, and financial statements or exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 18, 2025.
What is MaxCyte, Inc.'s state of incorporation and IRS Employer Identification Number?
MaxCyte, Inc. is incorporated in Delaware and has an IRS Employer Identification Number of 52-2210438.
What is MaxCyte, Inc.'s business and mailing address?
MaxCyte, Inc.'s business and mailing address is 9713 Key West Avenue, Suite 400, Rockville, MD 20850.
What is the SIC code for MaxCyte, Inc.?
MaxCyte, Inc.'s Standard Industrial Classification (SIC) code is 8731, which falls under SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding MAXCYTE, INC. (MXCT).